Enoxaparin sodium biosimilar (Biocad)
依诺肝素钠生物类似药 (Biocad)
Report date: 2022/07/19 20:00:45
Base Information
Drug NameEnoxaparin sodium biosimilar (Biocad)
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPending (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesBIOCAD JSC
China Registration ClassN/A
Develop Information
Other Information
ATC Code
Related LinksN/A